Moreover, HNF1B showed high mutation levels in Esophagogastric Adenocarcinoma, Endometrial Carcinoma, Pancreatic Adenocarcinoma, Melanoma, Invasive Breast Carcinoma, Bladder Urothelial Carcinoma, Colorectal Adenocarcinoma, Sarcoma, Ovarian Epithelial Tumor, Cervical Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Glioblastoma, Diffuse Glioma, Pheochromocytoma and Renal Non-Clear Cell Carcinoma. This evidence concerns the gene HNF1B and pancreatic adenocarcinoma.